NGM Bio Announces Multiple Aldafermin (NGM282) Poster Presentations at Upcoming AASLD’s The Liver Meeting®

NEXT STORY
Calithera Biosciences Completes Patient Enrollment in Randomized CANTATA Trial of Telaglenastat and Cabozantinib in Advanced Renal Cell Carcinoma
PREV STORY
Aktiekapitalet i Oncology Venture ökar till följd av nyttjade tecknings­optioner
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

GigaGen to Present Poster at the 2021 American Association for Cancer Research (AACR) Virtual Annual Meeting

author_avatar
NASDAQ Market News

Revive Therapeutics Provides Update on Oral Thin Film Product with Psilocybin

author_avatar
NASDAQ Market News

New Study From Trusted Health Finds Significant Decline in Nurses’ Mental Health and Well-being in the Wake of COVID-19, Yet Commitment to the Profession Remains High

author_avatar
NASDAQ Market News